SNAPLVV
Live / Registered — Registered (as of 17 Feb 2026)
What this means for you
Registered since 17 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98313178
- Registration number
- 8146203
- Mark type
- Stylized text
- Filed
- 13 Dec 2023
- Published for opposition
- 15 Oct 2024
- Registered
- 17 Feb 2026
- Attorney of record
- Susan M. Natland
Goods and services
- Class 040 — Treatment of materials: Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing for others, namely, platforms for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology
- Class 042 — Scientific and technological services: Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services, namely, research in the field of genetics; biotechnology research and development; scientific, pharmaceutical, and medical research services in the field of biological treatment and bioproduction; design and development of biotechnology platforms relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; providing scientific research information, namely, provision of information for research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services, namely, the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins
Owner
- National Resilience, Inc., San Diego, CA, US
- National Resilience, Inc., San Diego, CA, US
- National Resilience, Inc., San Diego, CA, US
Prosecution history
- 17 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 11 Feb 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 11 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Feb 2026 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 26 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 12 May 2025 — USE AMENDMENT FILED
- 14 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 May 2025 — TEAS STATEMENT OF USE RECEIVED